Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Tiggeler

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 1, 1972
[Malignant hypertension; practical and theoretical lecture on account of one patient]P G Wijdeveld, R G Tiggeler
Kidney International|September 1, 1979
Effect of indomethacin on glomerular permeability in the nephrotic syndromeR G Tiggeler, B Hulme, P G Wijdeveld
Clinical Science and Molecular Medicine|February 1, 1977
Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndromeR G Tiggeler, R A Koene, P G Wijdeveld
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
Incidence and clinical course of de-novo malignancies in renal allograft recipientsJ T Winkelhorst, W J Brokelman, R G Tiggeler, et al.
Lancet (London, England)|December 24, 1988
Intraperitoneal erythropoietinL A Frenken, P J Coppens, R G Tiggeler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Pneumocystis carinii pneumonia in renal transplant recipientsA J Branten, P J Beckers, R G Tiggeler, et al.
Annals of Surgery|February 1, 1985
Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydrationR G Tiggeler, J H Berden, A J Hoitsma, et al.
Lancet (London, England)|April 29, 1989
Intraperitoneal erythropoietinL A Frenken, P J Coppens, R G Tiggeler, et al.
Clinical Pharmacokinetics|December 1, 1988
Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysisT B Vree, M Martea, R G Tiggeler, et al.
Transplantation Proceedings|February 1, 1989
Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppressionA J Hoitsma, R G Tiggeler, J F Wetzels, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|January 1, 1972
[Malignant hypertension; practical and theoretical lecture on account of one patient]P G Wijdeveld, R G Tiggeler
Kidney International|September 1, 1979
Effect of indomethacin on glomerular permeability in the nephrotic syndromeR G Tiggeler, B Hulme, P G Wijdeveld
Clinical Science and Molecular Medicine|February 1, 1977
Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndromeR G Tiggeler, R A Koene, P G Wijdeveld
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
Incidence and clinical course of de-novo malignancies in renal allograft recipientsJ T Winkelhorst, W J Brokelman, R G Tiggeler, et al.
Lancet (London, England)|December 24, 1988
Intraperitoneal erythropoietinL A Frenken, P J Coppens, R G Tiggeler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Pneumocystis carinii pneumonia in renal transplant recipientsA J Branten, P J Beckers, R G Tiggeler, et al.
Annals of Surgery|February 1, 1985
Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydrationR G Tiggeler, J H Berden, A J Hoitsma, et al.
Lancet (London, England)|April 29, 1989
Intraperitoneal erythropoietinL A Frenken, P J Coppens, R G Tiggeler, et al.
Clinical Pharmacokinetics|December 1, 1988
Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysisT B Vree, M Martea, R G Tiggeler, et al.
Transplantation Proceedings|February 1, 1989
Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppressionA J Hoitsma, R G Tiggeler, J F Wetzels, et al.
Pageof 2